PubMed

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B.

Comp Hepatol. 2004 Sep 23;3(1):8.PMID: 15387887 [PubMed - as supplied by publisher]Related articlesFree article

Discordance between biochemical markers of liver activity and fibrosis (Actitest((R))-Fibrotest((R))) and liver biopsy in patients with chronic hepatitis C.

Fontanges T, Bailly F, Trepo E, Chevallier M, Maynard-Muet M, Nalet B, Beorchia S, Pillon D, Moindrot H, Froissart B, Slaoui M, Tinel X, Pradat P, Trepo C.

Gastroenterol Clin Biol. 2008 Sep 3. [Epub ahead of print]PMID: 18775614 [PubMed - as supplied by publisher]Related articlesFree article

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, Rotily M, Sattonet C, Benderitter T, Saint Paul MC, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D.

Am J Gastroenterol. 2006 Mar;101(3):547-55.PMID: 16542291 [PubMed - indexed for MEDLINE]Related articles

Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.

Poynard T, Ngo Y, Marcellin P, Hadziyannis S, Ratziu V, Benhamou Y; Adefovir Dipivoxil 437 and 438 Study Groups.

J Viral Hepat. 2009 Mar;16(3):203-13. Epub 2008 Oct 22.PMID: 19175871 [PubMed - indexed for MEDLINE]Related articles

Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V.

BMC Gastroenterol. 2007 Oct 15;7:40.PMID: 17937811 [PubMed - indexed for MEDLINE]Related articlesFree article

Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.

El-Shabrawi MH, Mohsen NA, Sherif MM, El-Karaksy HM, Abou-Yosef H, El-Sayed HM, Riad H, Bahaa N, Isa M, El-Hennawy A.

Eur J Gastroenterol Hepatol. 2010 Jan 27. [Epub ahead of print]PMID: 20110820 [PubMed - as supplied by publisher]Related articles

FibroTest-ActiTest as a non-invasive marker of liver fibrosis.

Halfon P, Munteanu M, Poynard T.

Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):22-39.PMID: 18973844 [PubMed - indexed for MEDLINE]Related articlesFree article

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T; LIDO Study Group; CYTOL study group.

BMC Gastroenterol. 2006 Feb 14;6:6.PMID: 16503961 [PubMed - indexed for MEDLINE]Related articlesFree article

Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.

Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P.

J Viral Hepat. 2006 Oct;13(10):659-70.PMID: 16970597 [PubMed - indexed for MEDLINE]Related articles

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.

Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T.

J Hepatol. 2003 Aug;39(2):222-30.PMID: 12873819 [PubMed - indexed for MEDLINE]Related articles

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.

Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M, Chaput JC, Poynard T.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):167-74.PMID: 15704051 [PubMed - indexed for MEDLINE]Related articles

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

Poynard T, Zoulim F, Ratziu V, Degos F, Imbert-Bismut F, Deny P, Landais P, El Hasnaoui A, Slama A, Blin P, Thibault V, Parvaz P, Munteanu M, Trepo C.

Am J Gastroenterol. 2005 Sep;100(9):1970-80.PMID: 16128941 [PubMed - indexed for MEDLINE]Related articles

The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.

Grigorescu M, Rusu M, Neculoiu D, Radu C, Serban A, Catanas M, Grigorescu MD.

J Gastrointestin Liver Dis. 2007 Mar;16(1):31-7.PMID: 17410286 [PubMed - indexed for MEDLINE]Related articlesFree article

[FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B]

Gui HL, Xie Q, Wang H.

Zhonghua Gan Zang Bing Za Zhi. 2008 Dec;16(12):897-901. Chinese. PMID: 19105932 [PubMed - in process]Related articles

Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.

Morali G, Maor Y, Klar R, Braun M, Ben Ari Z, Bujanover Y, Zuckerman E, Boger S, Halfon P.

Isr Med Assoc J. 2007 Aug;9(8):588-91.PMID: 17877064 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.

Alric L, Kamar N, Bonnet D, Danjoux M, Abravanel F, Lauwers-Cances V, Rostaing L.

Transpl Int. 2009 May;22(5):568-73. Epub 2009 Jan 29.PMID: 19196449 [PubMed - indexed for MEDLINE]Related articles

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest).

Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J, Piton A, Bonyhay L, Ratziu V, Hainque B, Poynard T.

Comp Hepatol. 2004 Jun 23;3(1):3.PMID: 15214966 [PubMed - as supplied by publisher]Related articlesFree article

Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-Meir S, Martinowitz U, Halfon P.

Haemophilia. 2006 Jul;12(4):372-9.PMID: 16834736 [PubMed - indexed for MEDLINE]Related articles

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.

Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Bonnefont-Rousselot D, Moussalli J, Ratziu V, Poynard T.

PLoS One. 2008 Jul 2;3(7):e2573. Erratum in: PLoS ONE. 2008;3(7). doi: 10.1371/annotation/9f8332b9-fdc0-48e8-967b-3c504024b9d1. Rousselot-Bonnefont, Dominique [corrected to Bonnefont-Rousselot, Dominique]. PMID: 18596917 [PubMed - indexed for MEDLINE]Related articlesFree article

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

Morra R, Munteanu M, Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):847-58.PMID: 17767469 [PubMed - indexed for MEDLINE]Related articlesFree article